Torrent Pharma executive director Pranav Mehta resigns

Torrent Pharmaceuticals announced the resignation of Pranav Mehta, Executive Director (Strategic Planning), effective from the close of business hours on February 26, 2025. The resignation was disclosed in a filing with the BSE (Scrip Code: 500420) and NSE (Scrip Code: TORNTPHARM) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding changes in Senior Management Personnel. The company confirmed that Mehta's resignation was voluntary, and further details, as required by SEBI regulations, are enclosed in Annexure-A. Torrent Pharmaceuticals stated that Mehta is committed to support the company by delivering a smooth transition and complete all handover formalities.